{"entity":{"type":"insider","cik":"0002034668","url":"/insider/0002034668","json_url":"/insider/0002034668.json","name":"Hyep Ivan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":11,"first":"2025-10-08","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Hyep Ivan","source":"filing","n_filings":11,"first_seen":"2025-10-08","last_seen":"2026-08-12"}],"transactions":[{"id":9289425,"accession":"0001470831-26-000814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000814","line_url":"/filing/0001470831-26-000814#line-1","is_derivative":false,"issuer_cik":"0002034668","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002034668","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":27.9673,"price_display":"27.97","price_state":"stated","total_value":349591.25,"total_display":"349,591.25","total_whole":"349,591","shares_owned_after":129855.0,"shares_owned_after_display":"129,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":5765556,"accession":"0001470831-26-000700","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001470831-26-000700","line_url":"/filing/0001470831-26-000700","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":28.84542720714286,"price_display":"28.85","price_state":"stated","total_value":807671.9618,"total_display":"807,671.96","total_whole":"807,672","shares_owned_after":135098.0,"shares_owned_after_display":"135,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-10","scope":"insider","n_lines":3},{"id":5933895,"accession":"0001628280-26-038248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-038248","line_url":"/filing/0001628280-26-038248#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":20.4221,"price_display":"20.42","price_state":"stated","total_value":187883.32,"total_display":"187,883.32","total_whole":"187,883","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-21","filed_date":"2026-05-26","scope":"insider"},{"id":5917851,"accession":"0001628280-26-026604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-026604","line_url":"/filing/0001628280-26-026604#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":23.0015,"price_display":"23.00","price_state":"stated","total_value":211613.8,"total_display":"211,613.80","total_whole":"211,614","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-22","scope":"insider"},{"id":6043637,"accession":"0001628280-26-020876","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-020876","line_url":"/filing/0001628280-26-020876#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":18.5161,"price_display":"18.52","price_state":"stated","total_value":170348.12,"total_display":"170,348.12","total_whole":"170,348","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-23","filed_date":"2026-03-24","scope":"insider"},{"id":5814304,"accession":"0001628280-26-015421","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-26-015421","line_url":"/filing/0001628280-26-015421#line-5","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2963.0,"shares_display":"2,963","price_per_share":18.2456,"price_display":"18.25","price_state":"stated","total_value":54061.7128,"total_display":"54,061.71","total_whole":"54,062","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":5814300,"accession":"0001628280-26-015421","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-015421","line_url":"/filing/0001628280-26-015421#line-3","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13555.0,"shares_display":"13,555","price_per_share":18.2154,"price_display":"18.22","price_state":"stated","total_value":246909.747,"total_display":"246,909.75","total_whole":"246,910","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider"},{"id":5962759,"accession":"0001628280-26-003418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-003418","line_url":"/filing/0001628280-26-003418#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1882.0,"shares_display":"1,882","price_per_share":18.1522,"price_display":"18.15","price_state":"stated","total_value":34162.4404,"total_display":"34,162.44","total_whole":"34,162","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-26","scope":"insider"},{"id":5063334,"accession":"0002034668-25-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002034668-25-000012","line_url":"/filing/0002034668-25-000012#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":18.3143,"price_display":"18.31","price_state":"stated","total_value":168491.56,"total_display":"168,491.56","total_whole":"168,492","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":4078879,"accession":"0002034668-25-000010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002034668-25-000010","line_url":"/filing/0002034668-25-000010#line-4","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17795.0,"shares_display":"17,795","price_per_share":18.5498,"price_display":"18.55","price_state":"stated","total_value":330093.691,"total_display":"330,093.69","total_whole":"330,094","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-25","scope":"insider"},{"id":4078872,"accession":"0002034668-25-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002034668-25-000010","line_url":"/filing/0002034668-25-000010#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":605.0,"shares_display":"605","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":10980.75,"total_display":"10,980.75","total_whole":"10,981","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-25","scope":"insider"},{"id":4216331,"accession":"0002034668-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002034668-25-000007","line_url":"/filing/0002034668-25-000007#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6415.0,"shares_display":"6,415","price_per_share":18.2278,"price_display":"18.23","price_state":"stated","total_value":116931.337,"total_display":"116,931.34","total_whole":"116,931","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-10","scope":"insider"},{"id":4078867,"accession":"0002034668-25-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0002034668-25-000004","line_url":"/filing/0002034668-25-000004#line-6","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5627.0,"shares_display":"5,627","price_per_share":18.208,"price_display":"18.21","price_state":"stated","total_value":102456.416,"total_display":"102,456.42","total_whole":"102,456","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-08","scope":"insider"},{"id":4078861,"accession":"0002034668-25-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002034668-25-000004","line_url":"/filing/0002034668-25-000004#line-4","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18244.0,"shares_display":"18,244","price_per_share":18.2189,"price_display":"18.22","price_state":"stated","total_value":332385.6116,"total_display":"332,385.61","total_whole":"332,386","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-08","scope":"insider"},{"id":4078852,"accession":"0002034668-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002034668-25-000004","line_url":"/filing/0002034668-25-000004#line-2","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034668","owner_name":"Hyep Ivan","owner_display_name":"Hyep Ivan","owner_url":"/insider/0002034668","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6514.0,"shares_display":"6,514","price_per_share":18.1695,"price_display":"18.17","price_state":"stated","total_value":118356.123,"total_display":"118,356.12","total_whole":"118,356","shares_owned_after":145355.0,"shares_owned_after_display":"145,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002023658","name":"Bicara Therapeutics Inc.","url":"/issuer/0002023658","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2025-10-08","last_seen":"2026-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002034668","retrieved_at":"2026-08-23T20:47:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}